Skip to main content

SYNACT · SynAct Pharma AB · Financials

17.2200 SEK +0.1000 (+0.58%) At close · Oct 6
Market Cap
968.77M SEK
Shares
56.00M

Income-statement, balance-sheet and cash-flow figures read from the company's own published financial reports.

Browse captured authority reports and their original financial labels

Revenue
0
FY2025 Revenue FY2021–FY2025
Net Income
-110.83M -34.5%
FY2025 Net Income FY2021–FY2025
Operating Cash Flow
-97.33M -9.1%
FY2025 Operating Cash Flow FY2021–FY2025

Chart any reported metric, KPI or segment over time — the full statement history lives here

Line Item FY2025 FY2024 FY2023 FY2022 FY2021
SEK 0 0 0 0 0
SEK 0 0 0 0 0
SEK 85.61M 49.31M 105.06M 70.07M 60.49M
SEK 31.54M 40.49M 44.83M 35.61M 16.23M
SEK -116.54M -89.98M -224.5M -105.71M -76.7M
SEK 3.87M 2.96M 830K 1.42M 110K
SEK -118.99M -90.83M -224.28M -107.07M -76.81M
SEK -8.17M -8.42M -8.47M -7.86M -7.51M
SEK -110.83M -82.4M -215.81M -99.21M -69.3M
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.

Debt Profile

Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.

Reported debt balances

Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.

Reported balanceAs ofAmountSource
Current lease liabilities 2025-12-31 SEK 616,000 ESEF Annual Report filed 2026-04-15
Noncurrent lease liabilities 2025-12-31 SEK 595,000 ESEF Annual Report filed 2026-04-15
Instrument and agreement coverage is incomplete. Additional filings are awaiting review.

Covenants

Covenant terms have not yet been verified for this profile.

The balance figures do not establish whether covenants apply or whether the company complies with them.

Loans, facilities and notes

The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.